Turkiye’s pharmaceutical industry has grappled with significant economic challenges such as the frequent upward revision of the pharmaceutical Euro exchange rate.

J&J is seeking approval of TREMFYA for paediatric conditions with the submission of two sBLA to the US Food and Drug Administration.

Novartis has entered a worldwide licence and partnership agreement with PTC Therapeutics for the development of PTC518.

The MHRA has also granted approval to Faron Pharmaceuticals to conduct the BEXMAB trial of Clevegen in the UK.

Fate has announced the retirement of president and CEO Scott Wolchko with Bob Valamehr set to assume the role from 1 January ...

The EMA’s CHMP has endorsed expanding the use of Palforzia to toddlers aged one to three years with peanut allergies.

CBC Group has completed the strategic acquisition of UCB's mature neurology and allergy business in China for $680m.

The research team at UQ has secured a grant of $344,000 from the National Foundation for Medical Research and Innovation.

There is no excerpt because this is a protected post.

The HIV vaccine space has seen dwindling research activity as drug manufacturers turn to PrEP therapies for preventive ...

The ESMP platform enables marketing authorisation holders to report shortages and will be mandatory from 2025.

University of Birmingham researchers have identified CD70 as a key target to reduce the risk of GVHD in blood cancer patients ...